Medical Devices Company Equity Stake For Sale in Noida, India

• Health-tech company developing India's certified closed-loop heat therapy wearables for therapeutic pain relief.
• The product series comprises 7 CDSCO-registered, ISO 13485-certified heat-therapy SKUs covering neck, back, knee, foot, bed, menstrual pain, and posture needs.
• The devices use a digital closed-loop temperature control system with an NTC temperature sensor and PCB controller to maintain programmed therapeutic temperatures between 40°C and 45°C, with a firmware-enforced 120-minute automatic cut-off.
• More than 2 lakh customers have been served to date. Among 15,421 first-time D2C buyers, Neck and Back are the leading products, accounting for 40% and 25% of purchases respectively.
• Generated net revenue of approximately INR 5.83 crore in FY 2025–26, representing 53.7% year-on-year growth, with trailing-twelve-month revenue of approximately INR 6.75 crore.
• Recorded 40,010 orders in the trailing twelve months, comprising 21,585 D2C and 18,425 Amazon orders. The most recent quarter grew 2.36x compared with the same quarter a year earlier.
• Sells through its own D2C website, Amazon, quick commerce, general trade, and OEM channels, with an average order value of approximately INR 1,870 and blended gross margin of around 60%.
• Repeat purchases are primarily driven by household expansion into additional body-part SKUs, with 11.9% of customers purchasing a second product category and 2.3% purchasing a third.
• Owns a 12,000 sq. ft. manufacturing facility in Noida with in-house R&D and a CDSCO-compliant testing laboratory.
• Manufacturing processes including sewing, ultrasonic welding, electronics assembly, and quality control are carried out in-house, with approximately 70% of components sourced within India.
• Current manufacturing capacity is approximately 50,000 units per month, with the company reporting approximately 50% lower COGS than imported equivalents.
• Holds ISO 13485 certification and CDSCO Class B medical device registration. Design patents have been filed and granted, with an additional patent filed for the hPulse compression-plus-heat architecture.
• BIS IS 302 has been applied for and a clinical validation study has been commissioned.
• The company has consulted 50 physiotherapists during product development, has 150+ general trade outlets, and has a physiotherapy clinic pilot underway.
• The business has backing from FirstPort Capital, Inflection Point Ventures, GlobalBees, and String Ventures.
• Product quality is reflected in a 1.7% warranty ratio across all channels, based on 661 cases against 40,010 trailing-twelve-month orders.
• The founder and CEO previously worked as a software engineer at Amazon and founded the company after experiencing chronic pain personally, using personal capital to develop the product.